GlassScriptPhysician profile
William Mayoral
NPI 1154360493
$4,903.10
in general payments reported to CMS, 2019-2025
20 companies · $846 in 2025
The $846 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,171 · 2020: $472 · 2021: $554 · 2022: $556 · 2023: $630 · 2024: $673 · 2025: $846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,149.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,859.01 | 2019-2025 | |
| Janssen Biotech, INC. | $833.25 | 2019-2025 | Stelara, Tremfya, Remicade |
| Takeda Pharmaceuticals U.S.A., INC. | $389.89 | 2019-2025 | Entyvio, Eohilia |
| Ipsen Biopharmaceuticals, INC | $287.63 | 2024-2025 | Iqirvo |
| Madrigal Pharmaceuticals | $259.08 | 2024-2025 | Rezdiffra, Resmetirom |
| Genzyme Corporation | $203.96 | 2022-2025 | |
| Pfizer INC. | $149.36 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $148.25 | 2023-2025 | Dupixent |
| Olympus America INC. | $136.14 | 2019-2024 | Evis Exera III Colonovideoscope |
| Medical Device Business Services, INC. | $116.50 | 2019 | |
| Merck Sharp & Dohme LLC | $114.60 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $87.73 | 2019-2022 | |
| Hoffmann-La Roche Limited | $86.25 | 2019 | |
| Intercept Pharmaceuticals, INC. | $75.30 | 2019-2023 | Ocaliva |
| Celgene Corporation | $56.97 | 2023-2024 | Zeposia |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Romark Laboratories, Lc | $43.35 | 2019 | |
| Amag Pharmaceuticals, INC. | $19.92 | 2019 | |
| Medtronic, INC. | $16.66 | 2025 | Gi Genius |
| Cook Medical LLC | $13.60 | 2021 | |
| Qol Medical, LLC | $5.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mayoral listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.